Updated chart on early #COVID19 treatment for #Molnupiravir, #nirmatrelvir (#Paxlovid), and #fluvoxamine #IDTwitter
Further summary of early #COVID outpatient treatment options by @DrToddLee including the data on Monoclonal antibodies. #MedTwitter #IDTwitter
When thinking about therpeutics as a MD, fundamental question is: "Does a drug have benefit?"
A medicine that reduces symptom duration = beneficial
A medicine that reduces deaths = also beneficial.
Waiting to recommend a med until there are data that it does all things = silly
A medicine that reduces symptom duration = beneficial
A medicine that reduces deaths = also beneficial.
Waiting to recommend a med until there are data that it does all things = silly
Loading suggestions...